Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Yeong-Shiau Pu"'
Autor:
Yu-Cheng Lu, Chao-Yuan Huang, Chia-Hsien Cheng, Kuo-How Huang, Yu-Chuan Lu, Po-Ming Chow, Yi-Kai Chang, Yeong-Shiau Pu, Chung-Hsin Chen, Shao-Lun Lu, Keng-Hsueh Lan, Fu-Shan Jaw, Pei-Ling Chen, Jian-Hua Hong
Publikováno v:
Scientific reports. 12(1)
To compare clinical outcomes between the use of robotic-assisted laparoscopic radical prostatectomy (RP) and radiotherapy (RT) with long-term androgen deprivation therapy (ADT) in locally advanced prostate cancer (PC), 315 patients with locally advan
Autor:
Yu-Chuan Lu, Chi-Shin Tseng, Yeong-Shiau Pu, Ming-Chieh Kuo, Chao-Yuan Huang, Chung-Hung Hong, Chung-Hsin Chen, Hong-Chiang Chang, Kuo-How Huang, I-Ni Chiang
Publikováno v:
Scientific Reports, Vol 9, Iss 1, Pp 1-7 (2019)
Scientific Reports
Scientific Reports
In this study, we investigated post-orchiopexy testicular growth of undescended testes (UDTs) at different primary locations and determined the risk factors for testicular atrophy (TA). We conducted a retrospective chart review of boys who had underg
Publikováno v:
Cryobiology. 98
We investigated the association between tumor location on multiparametric magnetic resonance imaging (mpMRI) and outcomes of prostate cancer patients after primary total prostate cryoablation (PTPC). Between March 2010 and December 2012, consecutive
Autor:
Hong-Chiang Chang, Yeong-Shiau Pu, Kuo-How Huang, Po-Ming Chow, Wei-Lun Huang, Chao-Yuan Huang
Publikováno v:
BMC Urology
BMC Urology, Vol 20, Iss 1, Pp 1-7 (2020)
BMC Urology, Vol 20, Iss 1, Pp 1-7 (2020)
Background Hyperglycemia is associated with series of process leading to oncogenesis. Evidence has shown that diabetes mellitus (DM) seems to be associated with poor prognosis in patients with bladder cancer. However, evidence on the effect of glycem
Autor:
Yeong-Shiau Pu, Chung-Hsin Chen
Publikováno v:
Cryobiology. 82:88-92
Purpose To investigate the efficacy and safety profile of 12-month adjuvant androgen-deprivation therapy (ADT) following total-gland cryoablation (TGC) in patients with high-risk localized prostate cancer (HRLPC). Materials and Methods This open-labe
Autor:
Hong-Jeng Yu, Chao-Yuan Huang, Yeong-Shiau Pu, Wei-Hsien Hou, Chia-Chun Wang, Yu-Chieh Tsai, Feng-Ming Hsu, Chiao-Ling Tsai, Jason Chia-Hsien Cheng
Publikováno v:
Chronobiology International. 33:210-219
This retrospective study tested the hypothesis that disease control and treatment-related toxicity in patients undergoing high-dose radiotherapy (HDRT) for prostate cancer varies in a circadian manner. Patients with localized prostate adenocarcinoma
Autor:
Yu-Chuan Lu, Chao-Yuan Huang, Po-Ming Chow, Hong-Chiang Chang, Yeong-Shiau Pu, Shih-Chun Hung, Chi-Shin Tseng, Kuo-How Huang, I-Ni Chiang, Ting-En Tai, Chung-Hsin Chen, Chung-Hung Hong
Publikováno v:
World journal of urology. 37(9)
To analyze the trifecta outcome (functional, anatomical, and surgical aspects) of surgical reconstruction for ureteral lesions and investigate the factors affecting the success rate of such reconstruction. We retrospectively reviewed the data of pati
Autor:
Hong-Chiang Chang, Chung-Hung Hong, Chi-Shin Tseng, Yu-Chuan Lu, Yeong-Shiau Pu, Kuo-How Huang, I-Ni Chiang, Jian-Hua Hong
Publikováno v:
Scientific Reports
Scientific Reports, Vol 7, Iss 1, Pp 1-6 (2017)
Scientific Reports, Vol 7, Iss 1, Pp 1-6 (2017)
This study reports the experience of our tertiary referral center and proposes a new indicator, the growth percentage ratio (GPR), for determining the optimal timing of surgical intervention. A retrospective review of boys who underwent orchiopexy fo
Publikováno v:
World Journal of Urology. 33:1487-1494
To evaluate the oncological outcomes and complications of patients with saturated prostate cryoablation. A cohort of 208 patients cumulatively treated between June 2008 and December 2012 qualified for study inclusion, each undergoing total-gland cryo
Autor:
Yeong-Shiau Pu, Shuo-Meng Wang, Kuo-How Huang, Hong-Jheng Yu, Chao-Yuan Huang, Jui-Shan Hsu, Po-Chin Liang, Yuan-Ju Lee, Po-Ming Chow
Publikováno v:
Journal of Endourology. 28:729-734
To provide clinical outcomes of the Resonance metallic ureteral stent in patients with malignant ureteral obstruction, as well as clinical factors predicting stent failure.Cancer patients who have received Resonance stents from July 2009 to March 201